MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 570.50
+5.00 (0.88%)
May 25, 2026, 5:29 PM CET
MedCap AB Market Cap
MedCap AB has a market cap or net worth of 8.49 billion as of May 22, 2026. Its market cap has increased by 30.03% in one year.
Market Cap
8.49B
Enterprise Value
8.58B
Revenue
2.18B
Ranking
n/a
PE Ratio
37.70
Stock Price
570.50
Market Cap Chart
Since July 4, 2006, MedCap AB's market cap has increased from 37.25M to 8.49B, an increase of 22,702.22%. That is a compound annual growth rate of 31.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 8.49B | 2.61% |
| Dec 30, 2025 | 8.28B | -6.99% |
| Dec 30, 2024 | 8.90B | 78.07% |
| Dec 29, 2023 | 5.00B | 55.89% |
| Dec 30, 2022 | 3.21B | 21.63% |
| Dec 30, 2021 | 2.64B | -22.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 53.45B |
| Sectra AB | 53.33B |
| Elekta AB | 23.15B |
| Vitrolife AB | 14.46B |
| Nolato AB | 13.63B |
| Xvivo Perfusion AB | 9.27B |
| CellaVision AB | 2.91B |
| Devyser Diagnostics AB | 1.62B |